Cargando…

Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia

BACKGROUND: Congenital adrenal hyperplasia (CAH) (OMIM #201910) is a complex disease most often caused by pathogenic variant of the CYP21A2 gene. We have designed an efficient multistep approach to diagnose and classify CAH cases due to CYP21A2 variant and to study the genotype‐phenotype relationshi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Dung V., Tran, Thinh H., Nguyen, Duc H., Luong, Long H., Le, Phuong T., Ta, Minh H., Ngo, Huong T. T., Nguyen, Mai P., Le‐Anh, Tuan P., Nguyen, Dat P., Bui, The‐Hung, Ta, Van T., Tran, Van K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503067/
https://www.ncbi.nlm.nih.gov/pubmed/30816000
http://dx.doi.org/10.1002/mgg3.623
_version_ 1783416346548109312
author Chi, Dung V.
Tran, Thinh H.
Nguyen, Duc H.
Luong, Long H.
Le, Phuong T.
Ta, Minh H.
Ngo, Huong T. T.
Nguyen, Mai P.
Le‐Anh, Tuan P.
Nguyen, Dat P.
Bui, The‐Hung
Ta, Van T.
Tran, Van K.
author_facet Chi, Dung V.
Tran, Thinh H.
Nguyen, Duc H.
Luong, Long H.
Le, Phuong T.
Ta, Minh H.
Ngo, Huong T. T.
Nguyen, Mai P.
Le‐Anh, Tuan P.
Nguyen, Dat P.
Bui, The‐Hung
Ta, Van T.
Tran, Van K.
author_sort Chi, Dung V.
collection PubMed
description BACKGROUND: Congenital adrenal hyperplasia (CAH) (OMIM #201910) is a complex disease most often caused by pathogenic variant of the CYP21A2 gene. We have designed an efficient multistep approach to diagnose and classify CAH cases due to CYP21A2 variant and to study the genotype‐phenotype relationship. METHODS: A large cohort of 212 Vietnamese patients from 204 families was recruited. We utilized Multiplex Ligation‐dependent Probe Amplification to identify large deletion or rearrangement followed by complete gene sequencing of CYP21A2 to map single‐nucleotide changes and possible novel variants. RESULTS: Pathogenic variants were identified in 398 out of 408 alleles (97.5%). The variants indexed span across most of the CYP21A2 gene regions. The most common genotypes were: I2g/I2g (15.35%); Del/Del (14.4%); Del/I2g (10.89%); p.R356W/p.R356W (6.44%); and exon 1–3 del/exon 1–3 del (5.44%). In addition to the previously characterized and documented variants, we also discovered six novel variants which were not previously reported, in silico tools were used to support the pathogenicity of these variants. CONCLUSION: The result will contribute in further understanding the genotype‐phenotype relationship of CAH patients and to guide better treatment and management of the affected.
format Online
Article
Text
id pubmed-6503067
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65030672019-05-10 Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia Chi, Dung V. Tran, Thinh H. Nguyen, Duc H. Luong, Long H. Le, Phuong T. Ta, Minh H. Ngo, Huong T. T. Nguyen, Mai P. Le‐Anh, Tuan P. Nguyen, Dat P. Bui, The‐Hung Ta, Van T. Tran, Van K. Mol Genet Genomic Med Original Articles BACKGROUND: Congenital adrenal hyperplasia (CAH) (OMIM #201910) is a complex disease most often caused by pathogenic variant of the CYP21A2 gene. We have designed an efficient multistep approach to diagnose and classify CAH cases due to CYP21A2 variant and to study the genotype‐phenotype relationship. METHODS: A large cohort of 212 Vietnamese patients from 204 families was recruited. We utilized Multiplex Ligation‐dependent Probe Amplification to identify large deletion or rearrangement followed by complete gene sequencing of CYP21A2 to map single‐nucleotide changes and possible novel variants. RESULTS: Pathogenic variants were identified in 398 out of 408 alleles (97.5%). The variants indexed span across most of the CYP21A2 gene regions. The most common genotypes were: I2g/I2g (15.35%); Del/Del (14.4%); Del/I2g (10.89%); p.R356W/p.R356W (6.44%); and exon 1–3 del/exon 1–3 del (5.44%). In addition to the previously characterized and documented variants, we also discovered six novel variants which were not previously reported, in silico tools were used to support the pathogenicity of these variants. CONCLUSION: The result will contribute in further understanding the genotype‐phenotype relationship of CAH patients and to guide better treatment and management of the affected. John Wiley and Sons Inc. 2019-02-27 /pmc/articles/PMC6503067/ /pubmed/30816000 http://dx.doi.org/10.1002/mgg3.623 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Chi, Dung V.
Tran, Thinh H.
Nguyen, Duc H.
Luong, Long H.
Le, Phuong T.
Ta, Minh H.
Ngo, Huong T. T.
Nguyen, Mai P.
Le‐Anh, Tuan P.
Nguyen, Dat P.
Bui, The‐Hung
Ta, Van T.
Tran, Van K.
Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
title Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
title_full Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
title_fullStr Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
title_full_unstemmed Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
title_short Novel variants of CYP21A2 in Vietnamese patients with congenital adrenal hyperplasia
title_sort novel variants of cyp21a2 in vietnamese patients with congenital adrenal hyperplasia
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503067/
https://www.ncbi.nlm.nih.gov/pubmed/30816000
http://dx.doi.org/10.1002/mgg3.623
work_keys_str_mv AT chidungv novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT tranthinhh novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT nguyenduch novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT luonglongh novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT lephuongt novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT taminhh novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT ngohuongtt novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT nguyenmaip novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT leanhtuanp novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT nguyendatp novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT buithehung novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT tavant novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia
AT tranvank novelvariantsofcyp21a2invietnamesepatientswithcongenitaladrenalhyperplasia